Clinical Trial Update: Pioglitazone Therapy Targeting Fatigue in Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating pioglitazone to target fatigue in patients with breast cancer, and recruitment is currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: West Virginia University | Conditions: Breast Cancer, Muscle Fatigue | Phase 2 | Status: RECRUITING